Vitasora Health Limited logo

Vitasora Health Limited (VHLUF)

Market Closed
7 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
2,000 Volume
- Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0.06
Want to track VHLUF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

VHLUF closed Friday higher at $0, an increase of 0% from Thursday's close, completing a monthly increase of 405% or $0. Over the past 12 months, VHLUF stock lost -94.7849%.
VHLUF is not paying dividends to its shareholders.
The last earnings report, released on Feb 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Vitasora Health Limited has completed 3 stock splits, with the recent split occurring on Jul 31, 2012.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on ASX (AUD).

VHLUF Chart

Vitasora Health Limited (VHLUF) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Vitasora Health Limited is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is VHLUF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Vitasora Health Limited ever had a stock split?

Vitasora Health Limited had 3 splits and the recent split was on Jul 31, 2012.

Vitasora Health Limited Profile

- Industry
- Sector
Mr. Marjan Mikel B.Sc., M.A.I.C.D. CEO
OTC PINK Exchange
AU0000392748 ISIN
Australia Country
- Employees
- Last Dividend
31 Jul 2012 Last Split
- IPO Date

Overview

Vitasora Health Limited is an innovative e-health software-as-a-service (SaaS) company that focuses on the research, development, and commercialization of medical devices and mobile health applications. With its headquarters located in Melbourne, Australia, Vitasora Health operates extensively within Australia and the United States. The company primarily emphasizes connected care management tailored for chronic disease management, targeting conditions such as cardiovascular disease, diabetes, obesity, and respiratory issues.

The flagship product of the company, Wheezo, is an FDA-approved wheeze rate detector that synergizes with mobile applications and health portals, allowing users to effectively monitor and track their respiratory health. Vitasora Health employs its comprehensive care management platform to extend healthcare providers' services beyond traditional clinical settings. This platform incorporates multi-device integration, AI-powered decision support, and virtual clinical assistance, enhancing the overall healthcare experience.

With a commitment to delivering data-driven and evidence-based programs, Vitasora Health plays a crucial role in facilitating critical patient health tracking services. The company's initiatives focus on improving patient engagement while assisting clinicians in bettering health outcomes, all within the framework of value-based care models. Founded in 1987 and currently led by CEO Marjan Mikel, Vitasora Health stands out as a significant force in the healthcare technology sector, utilizing advanced digital tools to aid in chronic disease management and remote patient monitoring.

Products and Services

  • Wheezo

    Wheezo is Vitasora's flagship product, a cutting-edge FDA-approved wheeze rate detector that seamlessly integrates with mobile applications and health portals. This product empowers individuals to monitor and track their respiratory health effectively, offering insights that can lead to better management of respiratory conditions.

  • Care Management Platform

    The Care Management Platform is designed to extend healthcare services beyond conventional clinical environments. It incorporates multi-device integration to streamline patient interactions and provides AI-powered decision support, ensuring clinicians have the necessary tools to make informed choices regarding patient care. This platform is vital for enhancing the effectiveness of chronic disease management.

  • Remote Patient Monitoring

    Vitasora Health’s remote patient monitoring service leverages digital tools to enable continuous tracking of patient health outside traditional settings. It fosters proactive management of chronic diseases, ensuring timely interventions based on real-time health data collected from patients, thereby improving overall healthcare delivery.

  • AI-Powered Decision Support

    Integrated within the care management platform, the AI-powered decision support system enhances clinical decision-making by providing actionable insights derived from data analytics. This technology allows healthcare providers to deliver personalized care tailored to individual patient needs, significantly improving health outcomes.

  • Virtual Clinical Assistance

    The virtual clinical assistance feature facilitates seamless communication between healthcare providers and patients, enabling support and guidance through digital channels. This service is particularly beneficial for individuals managing chronic diseases, as it allows for prompt attention to patient inquiries and concerns, ensuring a more engaging healthcare experience.

Contact Information

Address: 432 St Kilda Road
Phone: 61 3 9653 9160